SOUTHWEST ONCOLOGY GROUP S0226 FOLLOW UP FORM S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer Source Form: NCI FormBuilder:


  1. 8/26/12 8/26/12 -
  2. 1/9/15 1/9/15 - Martin Dugas
Uploaded on:

January 9, 2015

To request one please log in.
License :
Creative Commons BY-NC 3.0 Legacy
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Breast Cancer NCT00075764 Follow-Up - SOUTHWEST ONCOLOGY GROUP S0226 FOLLOW UP FORM - 2173463v3.0

No Instruction available.

    1. No Instruction available.
Vital Status
Vital Status
Disease Follow Up Status
Has the patient had a documented clinical assessment for this cancer since submission of the previous follow-up form?
Notice Of First Relapse Or Progression
Has the patient developed a first relapse or progression that has not been previously reported?
Notice Of New Primary
Has a new primary cancer or myelodysplastic syndrome (MDS) been diagnosed that has not been previously reported?
Non-protocol Treatment
Has the patient received any non-protocol cancer therapy not previously reported?
Long Term Toxicity
Has the patient experienced (prior to treatment for progression or relapse or a second primary, and prior to non-protocol treatment) any severe (grade >= 3) long term toxicity that has not been previously reported?
Ccrr Module For Southwest Oncology Group S0226 Follow Up Form

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial